We are looking for a JUNIOR PATHOLOGIST (at least 1 year of residency training) to join our group and lead one of our translational efforts in kidney cancer. Please contact us if you are interested and willing to spend at least 2 years in the lab.

🟢 Outstanding presentation at #KCRS24 ROHIT MEHRA 🟠 Role of Pathologist in Kidney Cancer Diagnostics and Research 🟠 Highlighting the morphologic diversity in renal tumors and its diagnostic implications. 🟠 Emphasis on understanding mechanisms to improve patient care.

We are super interested in the IVC thrombus UT Southwestern Urology UTSW Simmons Cancer Center UTSW Hematology & Oncology! Payal Kapur shows IVC correlates and Angioscore for as a biomarker for angiogenic driven tumor. KidneyCancerProgram #KCRS24 KidneyCAN

Sarcomatoid RCC #kidneycancer : Diagnostic Updates and Therapeutic Implications. Comprehensive talk by Sabina Signoretti Brigham and Women's Hospital 👉epigenomics, genetics and inflammed phenotype of Sarcomatoid RCC & Rx implications #KCRS24 KidneyCAN Toni Choueiri, MD Talal El Zarif, MD OncoAlert

Kicking off the Trials in Progress session with #ARCITECT evaluating Botensilimab+Balstilimab for pts with mRCC A trial that aims to "raise the tail" and a fantastic presentation by Michael Serzan, MD #KCRS24 KidneyCAN OncoAlert

Great work from these presenters!

The #INTerpath-004 trial explores the combination of pembro + personalized mRNA #vaccine for the adjuvant treatment of pts with RCC. Inspiring talk by Toni Choueiri, MD at #KCRS24! KidneyCAN Dana-Farber Lank Center for Genitourinary Oncology OncLive.com

Thank you Chuck for sharing! It’s very inspiring! Advocacy, research, and patient care unite to accelerate the cure! We can’t do it alone – we need each other! KidneyCAN Toni Choueiri, MD Bryan Lewis #KCRS24 OncoAlert Chuck Stravin #Advocate Hans Hammers Neeraj Agarwal, MD, FASCO Emre Yekedüz

Brilliant insights from Tom Powles Barts Cancer Institute (Queen Mary). Excellent use of Twitter polls to reconcile tough clinical scenarios (eg IO rechallenge following adj pembro). Shocking to hear rates of IO receipt in real world series - great point from Tom - use the best tx first. Toni Choueiri, MD

#KCRS24 Session 8: Rapid Abstract Presentations are underway! Tertiary Lymphoid Structures in Sarcomatoid RCC Nick Salgia Brain-Specific Tropism in mRCC Roy Elias Latino Ethnicity & Gut Microbiome in mRCC Regina Barragan-Carrillo #KidneyCancer #AcceleratingCures

Wrapping #kcrs24! Started my day with rock the run 5k and finished it with insightful discussions and inspiring moments. So glad to be part of kidney cancer research but also part of a great team along the way of curing this cancer!

Phase 1/2 Design of the HIF2a inhibitor NKT2152-101 showed response rate of 20% with an ‘in class’ toxicity profile #ESMO24 . The long half like makes it distinct and there in now a dose to take to randomised trials. Advantages over belzurifan are unclear. 2 doses being pursued.

Celebrating Dr Sabina Signoretti Brigham and Women's Hospital work and dedication over the years to Dana-Farber Brigham and Women's Hospital DF/HCC Pathology! cc: Signoretti Lab KaelinLab Harvard Medical School

Thanks to our friends at Cure Today for letting me share some advice for new patients. 👊👊 ⁦Dana-Farber⁩ ⁦Toni Choueiri, MD⁩ ⁦Dana-Farber Lank Center for Genitourinary Oncology⁩ ⁦KidneyCAN⁩ ⁦The Jimmy Fund⁩ ⁦Dana-Farber News⁩ curetoday.com/view/finding-s…

#KCRS25 Oral Abstract: berkay şimşek🌻 Brigham and Women's Hospital links CD163+ macrophages in RCC tumors to better outcomes with nivolumab. A potential new target for immunotherapy. Read all the abstracts: bit.ly/AbstractsKCRS25 Register: bit.ly/RegisterKCRS25 #AcceleratingCures

Pathologist representation at this year’s #KCRS25, one of my most important and favorite meetings each year. 🔬🩺🩻 #gupathology #workingtogethertofightRCC Payal Kapur Ying-Bei Chen, MD, PhD ROHIT MEHRA KidneyCAN OncoAlert UroToday.com

The #KCRS2025 ⁦KidneyCAN⁩ is also about ART!

So proud to be part of this incredible research team! #KCRS25 #pathology #kidneycancer KidneyCAN

Many congratulations Berkay Simsek for being a recipient of the KCRS 2025 Merit Awards for Translational Research berkay şimşek🌻 KidneyCAN Mass General Brigham #KCRS25 #kidneycancer